Delivery Order SPE2DX22D0049-SPE2D825FA6HM

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $22K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999.00. The delivery order has a ceiling value of $190,504.95 and is for the provision of a range of pharmaceutical products and medical supplies, including medications across various therapeutic areas such as diabetes, neurology, pain management, and antibiotics, to support military healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00. The delivery order, worth $1,349.90, is for the procurement of various pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and specialized medical supplies. The contract is a firm fixed-price,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00. The delivery order, worth $1,623.40, is for the procurement of various pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The contract is not set aside and is awarded...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under the company's existing Indefinite Delivery Contract (IDC) with DLA valued at $999,999,999.00. The delivery order has a ceiling value of $730,597.75 and a period of performance through May 24, 2024. It is a firm-fixed-price contract for the provision of a variety of pharmaceutical products and medical supplies, including medications across multiple...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes and vials, to support military treatment facilities, veterans'...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00. The delivery order, worth $822,842.83, is for the supply of a variety of pharmaceutical products and medical supplies to support military healthcare programs, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,750.82, is for the supply of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The delivery order is not set aside and is part of a larger Indefinite...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,064.40, is for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract, which runs through November 2026, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The order is for $43,473.78 and covers a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has a completion date of January 15, 2025 and does not have a set-aside...
  • SPE2DX22D0049
    Indefinite Delivery Contract
  • SPE2DX22D0049-SPE2D825FA6HM
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the DLA's Indefinite Delivery Contract (IDC) vehicle SPE2DX valued at $999,999,999.00. The delivery order, valued at $22,254.36, is for the procurement of various pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 29, 2025. As a prime contractor under the DLA's IDC, AmerisourceBergen Drug Corp is a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/28/25, 11:02 AM